Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: Neurogastroenterol Motil. 2017 Jan 9;29(6):10.1111/nmo.13018. doi: 10.1111/nmo.13018

Table 2.

Quantitative immunolabeling data for patients with diabetic gastroparesis, idiopathic gastroparesis and controls. A HPF represents 0.0367 mm2.

Cellular marker Diabetic
Gastroparesis
(n=11,
Mean/HPF ±
SEM)		 Idiopathic
Gastroparesis
(n=6,
Mean/HPF ±
SEM)		 Controls
(n=5,
Mean/HPF
± SEM)		 ANOVA
(p
value)
c-Kit
(Circular Muscle)		 2.28± 0.16 2.53± 0.47 6.05± 0.62 0.004
CD45
(Circular Muscle)		 13.82± 1.09 11.38± 0.54 19.25±4.05 0.07
CD45
(Myenteric plexus)		 14.72± 0.61 18.34± 2.24 22.90± 3.15 0.09
CD206
(Circular Muscle)		 3.87±0.32 4.16±0.52 6.59±1.09 0.04
CD206
(Myenteric plexus)		 3.83±0.27 3.59±0.68 7.46±0.51 0.004
PGP
(Circular Muscle)		 33.64± 3.45 41.26± 6.40 46.80±6.04 0.13
Substance P
(Circular Muscle)		 26.13±2.41 29.48± 3.87 21.67±1.38 0.25
VIP
(Circular Muscle)		 20.65± 2.19 26.32± 2.83 22.37± 3.89 0.33
n NOS Neurons
(Myenteric plexus)		 1.85± 0.12 2.00± 0.34 2.07±0.30 0.82
n NOS
(Circular Muscle)		 27.15± 2.95 35.43±4.75 26.57±3.90 0.27
Tyrosine Hydroxylase
(Myenteric plexus)		 32.50± 4.01 41.57±4.69 38.32±4.67 0.30